The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Rutgers startup Zena Therapeutics is working to develop safer medications that would minimize or even eliminate overdoses ...
Many prescription drugs have side effects. In fact, drug companies frequently include a list of side effects on their drugs’ ...